|
1
|
Nickoloff BJ and Nestle FO: Recent
insights into the immunopathogenesis of psoriasis provide new
therapeutic opportunities. J Clin Invest. 113:1664–1675. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leonardi CL, Powers JL, Matheson RT, Goffe
BS, Zitnik R, Wang A and Gottlieb AB; Etanercept Psoriasis Study
Group, : Etanercept as monotherapy in patients with psoriasis. N
Engl J Med. 349:2014–2022. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Menter A, Korman NJ, Elmets CA, Feldman
SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW,
et al: Guidelines of care for the management of psoriasis and
psoriatic arthritis: Section 4. Guidelines of care for the
management and treatment of psoriasis with traditional systemic
agents. J Am Acad Dermatol. 61:451–485. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gudjonsson JE, Johnston A, Dyson M,
Valdimarsson H and Elder JT: Mouse models of psoriasis. J Invest
Dermatol. 127:1292–1308. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ungureanu A, Zlatian O, Mitroi G, Drocaş
A, Ţîrcă T, Călina D, Dehelean C, Docea AO, Izotov BN, Rakitskii
VN, et al: Staphylococcus aureus colonisation in patients
from a primary regional hospital. Mol Med Rep. 16:8771–8780. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cargill M, Schrodi SJ, Chang M, Garcia VE,
Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese
JJ, et al: A large-scale genetic association study confirms IL12B
and leads to the identification of IL23R as psoriasis-risk genes.
Am J Hum Genet. 80:273–290. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krueger JG: The immunologic basis for the
treatment of psoriasis with new biologic agents. J Am Acad
Dermatol. 46:1–26. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reich K, Nestle FO, Papp K, Ortonne JP,
Evans R, Guzzo C, Li S, Dooley LT and Griffiths CE; EXPRESS study
investigators, : Infliximab induction and maintenance therapy for
moderate-to-severe psoriasis: A phase III, multicentre,
double-blind trial. Lancet. 366:1367–1374. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nomura I, Goleva E, Howell MD, Hamid QA,
Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, et al:
Cytokine milieu of atopic dermatitis, as compared to psoriasis,
skin prevents induction of innate immune response genes. J Immunol.
171:3262–3269. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stern RS, Nijsten T, Feldman SR, Margolis
DJ and Rolstad T: Psoriasis is common, carries a substantial burden
even when not extensive, and is associated with widespread
treatment dissatisfaction. J Investig Dermatol Symp Proc.
9:136–139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gottlieb AB, Evans R, Li S, Dooley LT,
Guzzo CA, Baker D, Bala M, Marano CW and Menter A: Infliximab
induction therapy for patients with severe plaque-type psoriasis: A
randomized, double-blind, placebo-controlled trial. J Am Acad
Dermatol. 51:534–542. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sani TA, Mohammadpour E, Mohammadi A,
Memariani T, Yazdi MV, Rezaee R, Calina D, Docea AO, Goumenou M,
Etemad L, et al: Cytotoxic and apoptogenic properties of
Dracocephalum kotschyi aerial part different fractions on
calu-6 and mehr-80 lung cancer cell lines. Farmacia. 65:189–199.
2017.
|
|
13
|
Ho SG, Yeung CK and Chan HH: Methotrexate
versus traditional Chinese medicine in psoriasis: A randomized,
placebo-controlled trial to determine efficacy, safety and quality
of life. Clin Exp Dermatol. 35:717–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu C, Deng J, Li L, Wang D and Li G:
Application of metabolomics on diagnosis and treatment of patients
with psoriasis in traditional Chinese medicine. Biochim Biophys
Acta. 1844:280–288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Geiger JM and Walker M: Is there a
reproductive safety risk in male patients treated with acitretin
(neotigason/soriatane?). Dermatology. 205:105–107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dogra S and Yadav S: Acitretin in
psoriasis: An evolving scenario. Int J Dermatol. 53:525–538. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang L, Wu X and Ma J: Traditional Chinese
medicine for the treatment of psoriasis vulgaris: A systematic
review. Afr J Microbiol Res. 6:7040–7047. 2012.
|
|
18
|
Liu C, Bi Z, Zhu Y and Li P: Simultaneous
determination of four kinds of bioactive components in radix
scrophulariae by HPLC. Chung Kuo Yao Hsueh Tsa Chih. 42:1614–1616.
2007.(In Chinese).
|
|
19
|
Allan BF, Dutra HP, Goessling LS, Barnett
K, Chase JM, Marquis RJ, Pang G, Storch GA, Thach RE and Orrock JL:
Invasive honeysuckle eradication reduces tick-borne disease risk by
altering host dynamics. Proc Natl Acad Sci USA. 107:18523–18527.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stpiczyńska M, Nepi M and Zych M:
Nectaries and male-biased nectar production in protandrous flowers
of a perennial umbellifer Angelica sylvestris L. (Apiaceae).
Plant Syst Evol. 301:1099–1113. 2015. View Article : Google Scholar
|
|
21
|
Zhang Y, Tu C, Zhang D, Zheng Y, Peng Z,
Feng Y, Xiao S and Li Z: Wnt/β-catenin and Wnt5a/Ca pathways
regulate proliferation and apoptosis of keratinocytes in psoriasis
lesions. Cell Physiol Biochem. 36:1890–1902. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawahira K: Immunohistochemical staining
of proliferating cell nuclear antigen (PCNA) in malignant and
nonmalignant skin diseases. Arch Dermatol Res. 291:413–418. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yonei T, Watanabe K, Sato T and Yamadori
I: Induction of psoriasis by human recombinant granulocyte colony
stimulating factor in a patient with small cell lung cancer. Nihon
Kokyuki Gakkai Zasshi. 39:438–441. 2001.(In Japanese). PubMed/NCBI
|
|
24
|
Mössner R, Beckmann I, Hallermann C,
Neumann C and Reich K: Granulocyte
colony-stimulating-factor-induced psoriasiform dermatitis resembles
psoriasis with regard to abnormal cytokine expression and epidermal
activation. Exp Dermatol. 13:340–346. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stoddart CA, Joshi P, Sloan B, Bare JC,
Smith PC, Allaway GP, Wild CT and Martin DE: Potent activity of the
HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice. PLoS
One. 2:e12512007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka
Y, Noguchi R, Hicklin DJ, Wu Y, Yanase K, Namisaki T, Yamazaki M,
et al: Vascular endothelial growth factor and receptor interaction
is a prerequisite for murine hepatic fibrogenesis. Gut.
52:1347–1354. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song XY, Sun LN, Zheng NN and Zhang HP:
Effect of hyperbaric oxygen preconditioning on spleen lymphocytes
and cell adhesion molecules after skin transplantation in mice.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 18:1275–1277. 2010.(In
Chinese). PubMed/NCBI
|
|
28
|
Koynova R, Tarahovsky YS, Wang L and
MacDonald RC: Lipoplex formulation of superior efficacy exhibits
high surface activity and fusogenicity, and readily releases DNA.
Biochim Biophys Acta. 1768:375–386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng H and Li X: Effect of white mange
medicine mixture on mice models of psoriasis. Chin J Derm Venerol
Integr Trad W Med. 11:149–151. 2012.
|
|
30
|
Kryczek I, Bruce AT, Gudjonsson JE,
Johnston A, Aphale A, Vatan L, Szeliga W, Wang Y, Liu Y, Welling
TH, et al: Induction of IL-17+ T cell trafficking and
development by IFN-γ: Mechanism and pathological relevance in
psoriasis. J Immunol. 181:4733–4741. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang XJ, Huang W, Yang S, Sun LD, Zhang
FY, Zhu QX, Zhang FR, Zhang C, Du WH, Pu XM, et al: Psoriasis
genome-wide association study identifies susceptibility variants
within LCE gene cluster at 1q21. Nat Genet. 41:205–210. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tyring S, Gottlieb A, Papp K, Gordon K,
Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, et al:
Etanercept and clinical outcomes, fatigue, and depression in
psoriasis: Double-blind placebo-controlled randomised phase III
trial. Lancet. 367:29–35. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiricozzi A, Guttman-Yassky E,
Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S and
Krueger JG: Integrative responses to IL-17 and TNF-α in human
keratinocytes account for key inflammatory pathogenic circuits in
psoriasis. J Invest Dermatol. 131:677–687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park JS, Rhyu JW, Kim CJ, Kim HS, Lee SY,
Kwon YI, Namkoong SE, Sin HS and Um SJ: Neoplastic change of
squamo-columnar junction in uterine cervix and vaginal epithelium
by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice. Gynecol
Oncol. 89:360–368. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Q, Peng T and Shi H: Effects of
BAIBI capsules on psoriatic mice and its mechanism of action. J
Pract Dermatol. 10:234–239. 2017.(In Chinese).
|
|
36
|
Liu H, Li Q, Wen X and Ye J: Xiaoyin no.
2′ effect of content on the histopathology and the content of PCNA
in psoriatic lesions of Guinea pig. J Yunnan Univ Tradit Chin Med.
38:13–16. 2015.(In Chinese).
|
|
37
|
Zhou Y and Yu R: Observation of combined
acitretin capsule and Xiaoyin granule therapy for 60 patients with
psoriasis vulgaris. Jilin Med J. 33:6504–6505. 2012.(In
Chinese).
|
|
38
|
Nanjappa MK, Medrano TI, March AG and
Cooke PS: Neonatal uterine and vaginal cell proliferation and
adenogenesis are independent of estrogen receptor 1 (ESR1) in the
mouse. Biol Reprod. 92:782015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou X, Krueger JG, Kao MC, Lee E, Du F,
Menter A, Wong WH and Bowcock AM: Novel mechanisms of T-cell and
dendritic cell activation revealed by profiling of psoriasis on the
63,100-element oligonucleotide array. Physiol Genomics. 13:69–78.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lew W, Bowcock AM and Krueger JG:
Psoriasis vulgaris: Cutaneous lymphoid tissue supports T-cell
activation and ‘Type 1’ inflammatory gene expression. Trends
Immunol. 25:295–305. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Laggner U, Di Meglio P, Perera GK,
Hundhausen C, Lacy KE, Ali N, Smith CH, Hayday AC, Nickoloff BJ and
Nestle FO: Identification of a novel proinflammatory human
skin-homing Vγ9Vδ2 T cell subset with a potential role in
psoriasis. J Immunol. 187:2783–2793. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fujita H, Shemer A, Suárez-Fariñas M,
Johnson-Huang LM, Tintle S, Cardinale I, Fuentes-Duculan J,
Novitskaya I, Carucci JA, Krueger JG, et al: Lesional dendritic
cells in patients with chronic atopic dermatitis and psoriasis
exhibit parallel ability to activate T-cell subsets. J Allergy Clin
Immunol. 128:574–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yuan Q and Li X: Experimental study on
regulating action of psoriasis model of guinea pig T cell
activation by TCM psoriasis mixture. Clin J Chin Med. 6:46–49.
2014.(In Chinese).
|
|
44
|
Chen X, Lu Y and Li X: Effects of white
mange mixture on Expression of CXCR2 protein of HaCaT cells and
content of IL-6. Zhonghua Zhongyiyao Xuekan. 33:2710–2712. 2015.(In
Chinese).
|
|
45
|
Xu W, Mao C, Feng R and Wang J:
Correlation analysis of blood heat syndrome with psoriasis vulgaris
and TH17 related cytokines. Guiding J Tradit Chin Med Pharm.
22:5–28. 2016.(In Chinese).
|
|
46
|
Kruglikov IL and Wollina U: The role of
subcutaneous adipose tissue in psoriasis. J Biol Regul Homeost
Agents. 32:159–161. 2018.PubMed/NCBI
|
|
47
|
Jobanputra P: Polyarteritis nodosa.
Diagnostic challenges in a patient with cutaneous vasculitis,
psoriasis, psoriatic arthritis and pancytopenia: Fatal progression
after treatment with G-CSF. Oxf Med Case Rep. 2016:86–90. 2016.
View Article : Google Scholar
|
|
48
|
Scholz T, Weigert A, Brüne B, Sadik CD,
Böhm B and Burkhardt H: GM-CSF in murine psoriasiform dermatitis:
Redundant and pathogenic roles uncovered by antibody-induced
neutralization and genetic deficiency. PLoS One. 12:e01826462017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Witte E, Kokolakis G, Witte K, Philipp S,
Doecke WD, Babel N, Wittig BM, Warszawska K, Kurek A,
Erdmann-Keding M, et al: IL-19 is a component of the pathogenetic
IL-23/IL-17 cascade in psoriasis. J Invest Dermatol. 134:2757–2767.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Martin G, Guérard S, Fortin MM, Rusu D,
Soucy J, Poubelle PE and Pouliot R: Pathological crosstalk in vitro
between T lymphocytes and lesional keratinocytes in psoriasis:
Necessity of direct cell-to-cell contact. Lab Invest. 92:1058–1070.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang C, Chen M and Tao C: Effect of baibi
ointment to psoriasis guinea pig model. J Chengdu Univ TCM.
34:55–57. 2011.(In Chinese).
|
|
52
|
Shi XL, Pan YM, Ma HY and Yang XF:
Treatment of psoriasis vulgaris by NB-UVB combined with traditional
Chinese materia medica bath: A clinical observation. Chin J Laser
Med Surg. 20:314–317. 2011.(In Chinese).
|
|
53
|
Buquicchio R, Foti C, Loconsole F,
Polimeno L and Ventura MT: Clusterin serum level: How does it
affect psoriatic patients? J Biol Regul Homeost Agents. 31:785–789.
2017.PubMed/NCBI
|
|
54
|
Cai Y, Zhang J, Yan Z, Zhang L, Yin J, Ren
Y, Zhang G, Yin Z and Li H: Effect of Caishi Xiaoyin on serum
levels of MCP-1, M-CSF and MIP-1 alpha in patients with psoriasis
vulgaris. Chin J Clin Ration Drug Use. 8:107–108. 2015.(In
Chinese).
|
